Literature DB >> 2553990

Unknotting the complexities of multidrug resistance: the involvement of DNA topoisomerases in drug action and resistance.

W T Beck1.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2553990     DOI: 10.1093/jnci/81.22.1683

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  20 in total

1.  Establishment of two new multi-drug resistant variants of the human tumor line Hep-2.

Authors:  A Redmond; E Law; U Gilvarry; M Clynes
Journal:  Cell Biol Toxicol       Date:  1990-07       Impact factor: 6.691

2.  Reversal of anticancer multidrug resistance by the ardeemins.

Authors:  T C Chou; K M Depew; Y H Zheng; M L Safer; D Chan; B Helfrich; D Zatorska; A Zatorski; W Bornmann; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

3.  In vivo etoposide-resistant C6 glioma cell line: significance of altered DNA topoisomerase II activity in multi-drug resistance.

Authors:  T Taki; T Ohnishi; N Arita; S Hiraga; T Hayakawa
Journal:  J Neurooncol       Date:  1998-01       Impact factor: 4.130

4.  Accumulation of anthracenyl-amino acid topoisomerase I and II inhibitors in drug-sensitive and drug-resistant human ovarian cancer cell lines determined by high-performance liquid chromatography.

Authors:  J Cummings; I Meikle; J S Macpherson; J F Smyth
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 5.  Cellular models for multiple drug resistance in cancer.

Authors:  M Clynes
Journal:  In Vitro Cell Dev Biol       Date:  1993-03

6.  Expression of mdr1 gene in human breast primary tumors and metastases.

Authors:  E Hennequin; C Delvincourt; C Pourny; J C Jardillier
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 7.  Topoisomerase II in multiple drug resistance.

Authors:  G A Hofmann; M R Mattern
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

Review 8.  Differing patterns of cross-resistance resulting from exposures to specific antitumour drugs or to radiation in vitro.

Authors:  B T Hill
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

9.  Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA.

Authors:  A V Gudkov; C R Zelnick; A R Kazarov; R Thimmapaya; D P Suttle; W T Beck; I B Roninson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

10.  Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A.

Authors:  M Clynes; A Redmond; E Moran; U Gilvarry
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.